Double-phase 18F-FDG PET-CT for determination of pulmonary tuberculoma activity

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 4, 2008, Pages 808-814

  Kim, In Ju ^a   Lee, Jung Sub ^a   Kim, Seong Jang ^a,b   Kim, Yong Ki ^a   Jeong, Yeon Joo ^a   Jun, Sungmin ^a   Nam, Hyun Yul ^a   Kim, Ju Sung ^b  

^a Pusan National University Hospital   (South Korea)

^b Silla University   (South Korea)

Author keywords

Double phase; FDG; PET; Standardized uptake value; Tuberculoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LUNG TUBERCULOSIS; MALE; POSITRON EMISSION TOMOGRAPHY; PREDICTOR VARIABLE; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TUBERCULOMA; ACUTE DISEASE; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY; RETROSPECTIVE STUDY; ROC CURVE; SCINTISCANNING;

ACUTE DISEASE; ADULT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TUBERCULOSIS, PULMONARY;

EID: 40949127067     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0585-0     Document Type: Article

References (29)

1. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis. Global trends and interactions with the HIV epidemic. Arch Int Med 2003;163:1009-21.
2. Sochocky S. Tuberculoma of the lung. Am Rev Tuberc 1958;78:403-10.
3. Toomes H, Delphendahl A, Manke HG, Vogt-Moykopf I. The coin lesion of the lung. A review of 955 resected coin lesions. Cancer 1983;51:534-7.
4. Zwirewich CV, Vedal S, Miller RR, Muller NL. Solitary pulmonary nodule: high resolution CT and radiologic-pathologic correlation. Radiology 1991;179:469-76.
5. Ishida T, Yokoyama H, Kaneko S, et al. Pulmonary tuberculoma and indications for surgery: radiographic and clinicopathological analysis. Respir Med 1992;86:431-6.
6. Lee HS, Oh JY, Lee JH, et al. Response of pulmonary tuberculomas to anti-tuberculous treatment. Eur Respir J 2004;23:452-5.
7. Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med 1996;37:943-8.
8. Gupta NC, Gill H, Graeber G, et al. Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions. Chest 1998;114:1105-11.
9. Gambhir SS, Shepherd JE, Shah BD, et al. Analytical decision model for the cost-effectiveness management of solitary pulmonary nodules. J Clin Oncol 1998;16:2113-25.
10. Goo JM, Im JG, Do KH, et al. Pulmonary tuberculoma evaluated by means of FDG PET: Findings in 10 cases. Radiology 2000;216:117-21.
11. Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Chest 1993;104:997-1002.
12. Brudin LH, Valind SO, Rhodes CG, et al. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med 1994;21:297-305.
13. 18F-FDG PET. J Nucl Med 2005;46:1819-24.
14. 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes. J Nucl Med 2006;47:1440-46.
15. 18F-FDG PET for the evaluation of gallbladder carcinoma. J Nucl Med 2006;47:633-8.
16. 18F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients. J Nucl Med 2003;44:1775-83.
17. 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 2002;43:871-5.
18. 18F-fluorocholine PET. J Nucl Med 2006;47:262-9.
19. 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001;42:1412-7.
20. Ishizu K, Nakamura S, Shiozaki T, et al. Increasing rate of FDG uptake from early to delayed PET images in lung tumors. J Nucl Med 2000;41: 76P(abstract).
21. Alavi A, Gupta N, Alberini JL, Hickeson M, Adam LE, Bhargava P, et al. Positron emission tomography imaging in nonmalignant thoracic disorders. Semin Nucl Med 2002;32:293-321.
22. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;161:1376-95.
23. Vansteenkiste JF, Stroobants SG, Dupont PJ, et al. FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localization of regional lymph node metastases? The Leuven Lung Cancer Group. Eur J Nucl Med 1998;25:1495-501.
24. 18F-fluoro-2- deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas. Cancer 2000;89:2547-54.
25. 18. F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med 2003;44:540-8.
26. Hamberg RM, Hunter GJ, Alpert NM, Choi NC, Babich JW, Fischman AJ. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med 1994;35:1308-12.
27. Hustinx R, Smith RJ, Benard F, et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. Eur J Nucl Med 1999;26:1345-8.
28. Wang YH, Lin AS, Lai YF, Chao TY, Liu JW, Ko SF. The high value of high resolution computed tomography in predicting the activity of pulmonary tuberculosis. Int J Tuberc Lung Dis 2003;7:563-8.
29. Tateishi U, Kusumoto M, Akiyama Y, Kishi F, Nishimura M, Moriyama N. Role of contrast-enhanced dynamic CT in the diagnosis of active tuberculoma. Chest 2002;122:1280-4.